Literature DB >> 9654087

Tyrosine phosphorylation of the muscle-specific kinase is exclusively induced by acetylcholine receptor-aggregating agrin fragments.

C Hopf1, W Hoch.   

Abstract

During formation of the neuromuscular junction, the basal membrane protein agrin initiates the aggregation of acetylcholine receptors (AChR) on the surface of myotubes. A muscle-specific kinase (MuSK) becomes phosphorylated upon incubation with agrin, although it does not bind to agrin on its own. Utilizing MuSK-specific antibodies, we demonstrate that the ability of different splicing variants and truncation fragments of agrin to trigger MuSK phosphorylation and AChR aggregation are correlated. Only agrin forms which are potent inducers of AChR-clustering are able to trigger the phosphorylation of MuSK. Picomolar concentrations of agrin are already sufficient to induce MuSK phosphorylation. Similar amounts are necessary for the aggregation of AChRs as well as their phosphorylation on a tyrosine residue. The complete overlap of specificities for MuSK phosphorylation and AChR aggregation suggests that only binding of agrin to a MuSK-containing receptor complex is responsible for the initiation of AChR aggregation. In contrast, interactions of agrin with binding proteins on the muscle surface harbouring different specificities such as alpha-dystroglycan do not seem to be necessary for this process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9654087     DOI: 10.1046/j.1432-1327.1998.2530382.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

Review 1.  Clustering of nicotinic acetylcholine receptors: from the neuromuscular junction to interneuronal synapses.

Authors:  Kyung-Hye Huh; Christian Fuhrer
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

2.  MuSK signaling at the neuromuscular junction.

Authors:  Qiang Wang; Bin Zhang; Wen-Cheng Xiong; Lin Mei
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

3.  Crystal structure of the agrin-responsive immunoglobulin-like domains 1 and 2 of the receptor tyrosine kinase MuSK.

Authors:  Amy L Stiegler; Steven J Burden; Stevan R Hubbard
Journal:  J Mol Biol       Date:  2006-09-12       Impact factor: 5.469

4.  Biglycan is an extracellular MuSK binding protein important for synapse stability.

Authors:  Alison R Amenta; Hilliary E Creely; Mary Lynn T Mercado; Hiroki Hagiwara; Beth A McKechnie; Beatrice E Lechner; Susana G Rossi; Qiang Wang; Rick T Owens; Emilio Marrero; Lin Mei; Werner Hoch; Marian F Young; David J McQuillan; Richard L Rotundo; Justin R Fallon
Journal:  J Neurosci       Date:  2012-02-15       Impact factor: 6.167

5.  Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes.

Authors:  David P Richman; Kayoko Nishi; Stuart W Morell; Jolene Mi Chang; Michael J Ferns; Robert L Wollmann; Ricardo A Maselli; Joachim Schnier; Mark A Agius
Journal:  Arch Neurol       Date:  2011-12-12

6.  Evidence of an agrin receptor in cortical neurons.

Authors:  L G Hilgenberg; C L Hoover; M A Smith
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

Review 7.  Genetic regulation of central synapse formation and organization in Drosophila melanogaster.

Authors:  Juan Carlos Duhart; Timothy J Mosca
Journal:  Genetics       Date:  2022-07-04       Impact factor: 4.402

8.  Animal models of antimuscle-specific kinase myasthenia.

Authors:  David P Richman; Kayoko Nishi; Michael J Ferns; Joachim Schnier; Peter Pytel; Ricardo A Maselli; Mark A Agius
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

9.  Lrp4 is a receptor for Agrin and forms a complex with MuSK.

Authors:  Natalie Kim; Amy L Stiegler; Thomas O Cameron; Peter T Hallock; Andrea M Gomez; Julie H Huang; Stevan R Hubbard; Michael L Dustin; Steven J Burden
Journal:  Cell       Date:  2008-10-09       Impact factor: 41.582

10.  O-fucosylation of muscle agrin determines its ability to cluster acetylcholine receptors.

Authors:  Mi-Lyang Kim; Kumaran Chandrasekharan; Matthew Glass; Shaolin Shi; Mark C Stahl; Brian Kaspar; Pamela Stanley; Paul T Martin
Journal:  Mol Cell Neurosci       Date:  2008-08-15       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.